Coave Therapeutics

Description: Coave Therapeutics develops targeted gene therapies for rare eye & CNS diseases using its ALIGATER platform to enhance treatment efficacy.

Country: France

Based in: Paris

Founded: 2014

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Genetics', 'Life Science', 'Neuroscience']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.